Advisory Committee on Immunization Practices (ACIP)
The ACIP is a group of medical and public health experts that develops recommendations on the use of vaccines in the civilian population of the United States. The ACIP holds three meetings each year at the Centers for Disease Control and Prevention (CDC), in Atlanta, Georgia to make vaccine recommendations. Meetings are open to the public and available online via webcast. More information on ACIP is available at: https://www.cdc.gov/vaccines/acip/index.html.
Select all docs (Max 200)
Narrow Results:
Publication Year
- 2024 93
- 2023 134
- 2022 233
- 2021 266
- 2020 167
- 2019 106
- 2018 132
- 2017 111
- 2016 96
- 2015 76
- 2014 116
- 2013 100
- 2012 109
- 2011 16
- 2010 24
- 2009 16
- 2008 17
- 2007 13
- 2006 16
- 2005 9
- 2004 8
- 2003 15
- 2002 11
- 2001 6
- 2000 10
- 1999 10
- 1998 5
- 1997 10
- 1996 10
- 1995 4
- 1994 7
- 1993 5
- 1992 5
- 1991 9
- 1990 6
- 1989 5
- 1988 4
- 1987 4
- 1986 4
- 1985 3
- 1984 4
- 1983 3
- 1982 3
- 1981 3
- 1980 2
- 1979 3
- 1978 3
- 1977 3
- 1976 7
- 1975 3
- 1974 3
- 1973 2
- 1972 3
- 1971 3
- 1970 2
- 1969 4
- 1968 3
- 1967 3
- 1966 2
- 1965 2
- 1964 1
Medical Subject
- Adolescent 110
- Adult 130
- Adverse Drug Reaction Reporting Systems 33
- Advisory Committees 65
- Aged 52
- Aged, 80 and over 13
- Age Factors 16
- Anthrax Vaccines 13
- BNT162 Vaccine 12
- Chikungunya Fever/prevention & control 13
- Child 141
- Child, Preschool 97
- Communicable Disease Control/standards 15
- Coronavirus Infections 16
- Coronavirus Infections/prevention & control 200
- Coronavirus Infections/prevention &control 47
- Cost-Benefit Analysis 18
- COVID-19 80
- COVID-19 Vaccines 258
- COVID-19 Vaccines/adverse effects 23
- COVID-19/prevention & control 119
- Decision Making 35
- Dengue 16
- Dengue/prevention & control 13
- Dengue Vaccines 32
- Diphtheria-Tetanus-acellular Pertussis Vaccines 22
- Disease Outbreaks 26
- Drug-Related Side Effects and Adverse Reactions 15
- Ebola Vaccines 17
- Female 34
- Full Report 21
- GRADE Approach 56
- Haemophilus Vaccines 15
- Health Personnel 18
- Hepatitis A Vaccines 27
- Hepatitis B Vaccines 39
- Herpes Zoster Vaccine 35
- Humans 147
- Immunization 345
- Immunization, Secondary 76
- Immunization/standards 54
- Immunization Programs 320
- Immunization Schedule 192
- Immunocompromised Host 16
- Infant 95
- Infant, Newborn 57
- Influenza, Human 42
- Influenza, Human/epidemiology 13
- Influenza, Human/prevention & control 36
- Influenza A Virus, H1N1 Subtype 13
- Influenza B virus 18
- Influenza Vaccines 176
- Influenza Vaccines/administration & dosage 17
- Influenza Vaccines/adverse effects 15
- Influenza Vaccines 12
- Japanese Encephalitis Vaccines 31
- Licensure 12
- Male 27
- Measles-Mumps-Rubella Vaccine 29
- Meningococcal Infections 15
- Meningococcal Vaccines 105
- Middle Aged 48
- Mpox (monkeypox)/prevention & control 15
- Myocarditis 13
- Pandemics 150
- Papillomavirus Vaccines 54
- Papillomavirus Vaccines 34
- Patient Safety 56
- Pertussis Vaccine 35
- Pneumococcal Infections 18
- Pneumococcal Vaccines 92
- Practice Guidelines as Topic 33
- Pregnancy 55
- Pregnant Women 27
- Program Evaluation 16
- Public Health Surveillance 13
- Rabies Vaccines 12
- Respiratory Syncytial Virus Infections/prevention & control 56
- Respiratory Syncytial Virus Infections/prevention & Control 14
- Respiratory Syncytial Virus Vaccines 48
- Respiratory Syncytial Virus Vaccines/economics 13
- Risk Assessment 18
- Safety 29
- SARS-CoV-2 13
- Seasons 20
- Smallpox Vaccine 27
- Travel 21
- Vaccination 630
- Vaccination/adverse effects 19
- Vaccination/standards 44
- Vaccine Efficacy 13
- Vaccines 376
- Vaccines, Attenuated 28
- Vaccines, Combined 23
- Vaccines, Conjugate 24
- Vaccines, Inactivated 21
- Vaccines/administration & dosage 51
- Vaccines/supply & distribution 18
- Viral Vaccines 170
- Young Adult 27
Personal Author
- Arden, Nancy H. 7
- Atmar, Robert L. 7
- Ault, Kevin 9
- Bell, Beth P. 39
- Belongia, Edward A. 8
- Bennett, Nancy M. 16
- Bocchini, Joseph A. 23
- Bower, William A. 8
- Brammer, Lynnette 11
- Bresee, Joseph S. 14
- Bridges, Carolyn B. 14
- Britton, Amadea 8
- Broder, Karen R. 21
- Brooks, Oliver 9
- Campos-Outcalt, Doug 15
- Chamberland, Mary 9
- Chen, Wilbur 10
- Chesson, Harrell W. 8
- Chung, Jessie R. 8
- Clark, Thomas A. 10
- Cohn, Amanda C. 22
- Cox, Nancy (Nancy J.) 22
- Coyne-Beasley, Tamera 7
- Daley, Matthew F. 32
- Dooling, Kathleen 31
- Duchin, Jeffrey S. 7
- Finelli, Lyn 7
- Fiore, Anthony E. 10
- Fischer, Marc 10
- Flannery, Brendan 11
- Frey, Sharon 9
- Fukuda, Keiji 8
- Gargano, Julia W. 7
- Gierke, Ryan 11
- Grohskopf, Lisa A. 51
- Hadler, Stephen C. 14
- Hall, Elisha 8
- Harpaz, Rafael 7
- Hills, Susan 14
- Hills, Susan L. 20
- Hopkins, Robert H. 12
- Hunter, Paul 9
- Hutton, David W. 8
- Iskander, John K. 8
- Jernigan, Daniel B. 7
- Jones, Jefferson 11
- Karron, Ruth A. 13
- Kim, David K. 11
- Kobayashi, Miwako 20
- Kroger, Andrew T. 15
- Lee, Grace M. 34
- Leidner, Andrew J. 8
- Liang, Jennifer L. 15
- Link-Gelles, Ruth 13
- Long, Sarah S. 8
- MacNeil, Jessica 14
- MacNeil, Jessica R. 9
- Marin, Mona 11
- Markowitz, Lauri E. 37
- Matanock, Almea 8
- Mbaeyi, Sarah A. 10
- McClung, Nancy 8
- Melgar, Michael 8
- Moore, Kelly L. 11
- Morgan, Rebecca L. 11
- Moulia, Danielle 9
- Nelson, Noele 11
- Nelson, Noele P. 8
- Oliver, Sara E. 54
- Ortega-Sanchez, Ismael R. 9
- Pickering, Larry K. 8
- Pilishvili, Tamara 25
- Poehling, Katherine 10
- Poehling, Katherine A. 16
- Rao, Agam 14
- Reingold, Arthur 18
- Robinson, Candice L. 10
- Romero, José R. 30
- Rubin, Lorry 19
- Sanchez, Pablo 8
- Santoli, Jeanne M. 30
- Sawyer, Mark 11
- Schillie, Sarah F. 8
- Shay, David K. 8
- Shimabukuro, Tom T. 45
- Sokolow, Leslie Z. 10
- Staples, J. Erin 10
- Stephens, David S. 13
- Stoecker, Charles 8
- Strikas, Raymond A. 8
- Su, John R. 8
- Szilagyi, Peter 8
- Talbot, H. Keipp 32
- Temte, Jonathan L. 10
- Twentyman, Evelyn 9
- Uyeki, Timothy M. 10
- Wallace, Megan 26
- Walter, Emmanuel B. 24
- Wharton, Melinda 10
- Williams, Walter W. 8
Corporate Author
- American Academy of Family Physicians 6
- American Academy of Family Physicians. 24
- American Academy of Pediatrics 4
- American Academy of Pediatrics. 4
- American Academy of Physician Assistants. 6
- American College of Nurse-Midwives. 16
- American College of Obstetricians and Gynecologists. 21
- American College of Physicians. 9
- Arkansas. Department of Health. 6
- Baylor College of Medicine. 4
- CDC COVID-19 Response Team. 9
- CDC COVID-19 Vaccine Planning Unit. Vaccine Safety Team. 6
- CDC COVID-19 Vaccine Task Force. Vaccine Safety Team. 14
- Center for Disease Control (U.S.). Immunization Practices Advisory Committee. 29
- Centers for Disease Control (U.S.). Immunization Practices Advisory Committee. 52
- Centers for Disease Control and Prevention (U.S.) 115
- Centers for Disease Control and Prevention (U.S.). Epidemic Intelligence Service. 9
- Centers for Disease Control and Prevention (U.S.). Immunization Safety Office. 5
- Communicable Disease Center (U.S.). Advisory Committee on Immunization Practices. 6
- COVID-19 Vaccine Safety Technical (VaST) Work Group. 9
- General Dynamics Information Technology. 4
- GlaxoSmithKline. 5
- GSK Vaccines. 11
- Kaiser Permanente Colorado. Institute for Health Research. 6
- Kaiser Permanente Vaccine Study Center. 8
- Marshfield Clinic Research Institute. 7
- Marshfield Clinic Research Institute. Vaccine Safety Datalink. Immunization Safety Office. 5
- McMaster University. Faculty of Health Sciences. Department of Health Research Methods, Evidence, and Impact. 5
- MedImmune, Inc. 6
- Merck Research Laboratories. 12
- Moderna (firm) 10
- Nancy Lee & Associates. 5
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.) 5
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Healthcare Quality Promotion. Immunization Safety Office. 16
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. 11
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. Poxvirus and Rabies Branch. 8
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. Viral Special Pathogens Branch. 6
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Vector-Borne Diseases. 5
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Vector-Borne Diseases. Arboviral Diseases Branch. 25
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Vector-Borne Diseases. Dengue Branch. 8
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Immunization Safety Office. 30
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Viral Special Pathogens Branch. 6
- National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.) 9
- National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of STD Prevention. 11
- National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Viral Hepatitis. 14
- National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention (U.S.). Division of Viral Hepatitis. 10
- National Center for Immunization and Respiratory Diseases (U.S.) 90
- National Center for Immunization and Respiratory Diseases (U.S.). Coronavirus and Other Respiratory Viruses Division. 7
- National Center for Immunization and Respiratory Diseases (U.S.). Division of Bacterial Diseases. 47
- National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. 66
- National Center for Immunization and Respiratory Diseases (U.S.). Immunization Services Division. 83
- National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. 53
- National Center for Immunization and Respiratory Diseases (U.S.). Meningitis and Vaccine Preventable Diseases Branch. 6
- National Center for Immunization and Respiratory Diseases (U.S.). Respiratory Diseases Branch. 9
- National Center for Immunization and Respiratory Diseases (U.S.). US Flu VE Network. 10
- National Center for Immunizations and Respiratory Diseases (U.S.). Respiratory Diseases Branch. 6
- National Center for Infectious Diseases (U.S.) 5
- National Center for Infectious Diseases (U.S.). Division of Viral and Rickettsial Diseases. 13
- National Communicable Disease Center (U.S.). Advisory Committee on Immunization Practices. 10
- National Immunization Program (Centers for Disease Control and Prevention) 22
- National Immunization Program (Centers for Disease Control and Prevention). Epidemiology and Surveillance Division. 7
- Pfizer Ltd. 9
- Sanofi Pasteur. 10
- Seqirus. 6
- Stanford University School of Medicine. 11
- Tulane University. School of Public Health and Tropical Medicine. 7
- United States, Advisory Committee on Immunization Practices. 15
- United States. Advisory Committee on Immunization Practices 9
- United States. Advisory Committee on Immunization Practices. 554
- United States. Advisory Committee on Immunization Practices. ACIP Flavivirus Vaccines Workgroup. 6
- United States. Advisory Committee on Immunization Practices. Adult Immunization Work Group. 10
- United States. Advisory Committee on Immunization Practices. Adult RSV Work Group. 15
- United States. Advisory Committee on Immunization Practices. Anthrax Vaccine Work Group. 11
- United States. Advisory Committee on Immunization Practices. Chikungunya Vaccines Work Group. 14
- United States. Advisory Committee on Immunization Practices. Combined Immunization Schedule Work Group. 5
- United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. 163
- United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. COVID-19 Vaccine Safety Technical (VaST) Subgroup. 5
- United States. Advisory Committee on Immunization Practices. Dengue Vaccine Workgroup. 7
- United States. Advisory Committee on Immunization Practices. Hepatitis Vaccines Work Group. 33
- United States. Advisory Committee on Immunization Practices. Herpes Zoster Work Group. 14
- United States. Advisory Committee on Immunization Practices. HPV Vaccines Work Group. 9
- United States. Advisory Committee on Immunization Practices. Human Rabies Prevention Work Group. 10
- United States. Advisory Committee on Immunization Practices. Influenza Work Group. 30
- United States. Advisory Committee on Immunization Practices. Influenza Workgroup. 6
- United States. Advisory Committee on Immunization Practices. JE Flavivirus Vaccine Workgroup. 5
- United States. Advisory Committee on Immunization Practices. Maternal/Pediatric Respiratory Syncytial Virus (RSV) Work Group. 7
- United States. Advisory Committee on Immunization Practices. Measles, Mumps, and Rubella (MMR) Vaccine Work Group. 6
- United States. Advisory Committee on Immunization Practices. Meningococcal Vaccines Work Group. 19
- United States. Advisory Committee on Immunization Practices. Meningococcal Work Group. 15
- United States. Advisory Committee on Immunization Practices. Mpox Vaccine Work Group. 9
- United States. Advisory Committee on Immunization Practices. Mumps Work Group. 5
- United States. Advisory Committee on Immunization Practices. Pertussis Vaccines Work Group. 18
- United States. Advisory Committee on Immunization Practices. Pertussis Vaccines Working Group. 5
- United States. Advisory Committee on Immunization Practices. Pneumococcal Vaccines Work Group. 46
- United States. Advisory Committee on Immunization Practices. Zoster Working Group. 5
- United States. Public Health Service. 7
- University of Michigan. School of Public Health. 7
- University of Washington. 10
- Valneva 5
- Vanderbilt University School of Medicine. 11
Place as Subject
- Africa 1
- Alabama 1
- Arizona 1
- Asia 4
- Australia 2
- California 1
- Colorado 1
- District of Columbia 1
- Indiana 1
- Los Angeles, CA 1
- Louisiana 1
- Maryland 1
- Minnesota 1
- New Jersey 1
- New Mexico 1
- New York City, NY 1
- New Zealand 1
- North Carolina 1
- Paraguay 1
- Puerto Rico 5
- Rhode Island 1
- Seattle, WA 1
- Sierra Leone 1
- South America 1
- United States 320
- Utah 1
- Washington 1
- Wisconsin 1
Resource Type General
- Agenda 84
- Agendas 32
- HAN Health Update 1
- Journal Article 126
- Journal Issue 100
- Meeting Minutes 11
- Minutes 201
- Pamphlet (or booklet) 41
- Presentation 1345
- Presentations 49
- Report 6
- Tables 1
- Text 1
- Webpage 7
Resource Type Specific
- Abbreviations 1
- Chronology 1
- Conference Publications 1624
- Fact Sheet 2
- Guidance 14
- Guideline 10
- Historical Article 1
- Map 1
- Practice Guideline 76
- Published Erratum 1
- Review 1
- Standards 2
Diseases And Conditions
1 -
20 of 2053 Results
SELECT A RANGE
SELECT A FORMAT
Refine Results:
- 2024 (93)
- 2023 (134)
- 2022 (233)
- 2021 (266)
- 2020 (167)
- 2019 (106)
- 2018 (132)
- 2017 (111)
- 2016 (96)
- 2015 (76)
- 2014 (116)
- 2013 (100)
- 2012 (109)
- 2011 (16)
- 2010 (24)
- 2009 (16)
- 2008 (17)
- 2007 (13)
- 2006 (16)
- 2005 (9)
- 2004 (8)
- 2003 (15)
- 2002 (11)
- 2001 (6)
- 2000 (10)
- 1999 (10)
- 1998 (5)
- 1997 (10)
- 1996 (10)
- 1995 (4)
- 1994 (7)
- 1993 (5)
- 1992 (5)
- 1991 (9)
- 1990 (6)
- 1989 (5)
- 1988 (4)
- 1987 (4)
- 1986 (4)
- 1985 (3)
- 1984 (4)
- 1983 (3)
- 1982 (3)
- 1981 (3)
- 1980 (2)
- 1979 (3)
- 1978 (3)
- 1977 (3)
- 1976 (7)
- 1975 (3)
- 1974 (3)
- 1973 (2)
- 1972 (3)
- 1971 (3)
- 1970 (2)
- 1969 (4)
- 1968 (3)
- 1967 (3)
- 1966 (2)
- 1965 (2)
- 1964 (1)
- Adolescent (110)
- Adult (130)
- Adverse Drug Reaction Reporting Systems (33)
- Advisory Committees (65)
- Aged (52)
- Aged, 80 and over (13)
- Age Factors (16)
- Anthrax Vaccines (13)
- BNT162 Vaccine (12)
- Chikungunya Fever/prevention & control (13)
- Child (141)
- Child, Preschool (97)
- Communicable Disease Control/standards (15)
- Coronavirus Infections (16)
- Coronavirus Infections/prevention & control (200)
- Coronavirus Infections/prevention &control (47)
- Cost-Benefit Analysis (18)
- COVID-19 (80)
- COVID-19 Vaccines (258)
- COVID-19 Vaccines/adverse effects (23)
- COVID-19/prevention & control (119)
- Decision Making (35)
- Dengue (16)
- Dengue/prevention & control (13)
- Dengue Vaccines (32)
- Diphtheria-Tetanus-acellular Pertussis Vaccines (22)
- Disease Outbreaks (26)
- Drug-Related Side Effects and Adverse Reactions (15)
- Ebola Vaccines (17)
- Female (34)
- Full Report (21)
- GRADE Approach (56)
- Haemophilus Vaccines (15)
- Health Personnel (18)
- Hepatitis A Vaccines (27)
- Hepatitis B Vaccines (39)
- Herpes Zoster Vaccine (35)
- Humans (147)
- Immunization (345)
- Immunization, Secondary (76)
- Immunization/standards (54)
- Immunization Programs (320)
- Immunization Schedule (192)
- Immunocompromised Host (16)
- Infant (95)
- Infant, Newborn (57)
- Influenza, Human (42)
- Influenza, Human/epidemiology (13)
- Influenza, Human/prevention & control (36)
- Influenza A Virus, H1N1 Subtype (13)
- Influenza B virus (18)
- Influenza Vaccines (176)
- Influenza Vaccines/administration & dosage (17)
- Influenza Vaccines/adverse effects (15)
- Influenza Vaccines (12)
- Japanese Encephalitis Vaccines (31)
- Licensure (12)
- Male (27)
- Measles-Mumps-Rubella Vaccine (29)
- Meningococcal Infections (15)
- Meningococcal Vaccines (105)
- Middle Aged (48)
- Mpox (monkeypox)/prevention & control (15)
- Myocarditis (13)
- Pandemics (150)
- Papillomavirus Vaccines (54)
- Papillomavirus Vaccines (34)
- Patient Safety (56)
- Pertussis Vaccine (35)
- Pneumococcal Infections (18)
- Pneumococcal Vaccines (92)
- Practice Guidelines as Topic (33)
- Pregnancy (55)
- Pregnant Women (27)
- Program Evaluation (16)
- Public Health Surveillance (13)
- Rabies Vaccines (12)
- Respiratory Syncytial Virus Infections/prevention & control (56)
- Respiratory Syncytial Virus Infections/prevention & Control (14)
- Respiratory Syncytial Virus Vaccines (48)
- Respiratory Syncytial Virus Vaccines/economics (13)
- Risk Assessment (18)
- Safety (29)
- SARS-CoV-2 (13)
- Seasons (20)
- Smallpox Vaccine (27)
- Travel (21)
- Vaccination (630)
- Vaccination/adverse effects (19)
- Vaccination/standards (44)
- Vaccine Efficacy (13)
- Vaccines (376)
- Vaccines, Attenuated (28)
- Vaccines, Combined (23)
- Vaccines, Conjugate (24)
- Vaccines, Inactivated (21)
- Vaccines/administration & dosage (51)
- Vaccines/supply & distribution (18)
- Viral Vaccines (170)
- Young Adult (27)
- Arden, Nancy H. (7)
- Atmar, Robert L. (7)
- Ault, Kevin (9)
- Bell, Beth P. (39)
- Belongia, Edward A. (8)
- Bennett, Nancy M. (16)
- Bocchini, Joseph A. (23)
- Bower, William A. (8)
- Brammer, Lynnette (11)
- Bresee, Joseph S. (14)
- Bridges, Carolyn B. (14)
- Britton, Amadea (8)
- Broder, Karen R. (21)
- Brooks, Oliver (9)
- Campos-Outcalt, Doug (15)
- Chamberland, Mary (9)
- Chen, Wilbur (10)
- Chesson, Harrell W. (8)
- Chung, Jessie R. (8)
- Clark, Thomas A. (10)
- Cohn, Amanda C. (22)
- Cox, Nancy (Nancy J.) (22)
- Coyne-Beasley, Tamera (7)
- Daley, Matthew F. (32)
- Dooling, Kathleen (31)
- Duchin, Jeffrey S. (7)
- Finelli, Lyn (7)
- Fiore, Anthony E. (10)
- Fischer, Marc (10)
- Flannery, Brendan (11)
- Frey, Sharon (9)
- Fukuda, Keiji (8)
- Gargano, Julia W. (7)
- Gierke, Ryan (11)
- Grohskopf, Lisa A. (51)
- Hadler, Stephen C. (14)
- Hall, Elisha (8)
- Harpaz, Rafael (7)
- Hills, Susan (14)
- Hills, Susan L. (20)
- Hopkins, Robert H. (12)
- Hunter, Paul (9)
- Hutton, David W. (8)
- Iskander, John K. (8)
- Jernigan, Daniel B. (7)
- Jones, Jefferson (11)
- Karron, Ruth A. (13)
- Kim, David K. (11)
- Kobayashi, Miwako (20)
- Kroger, Andrew T. (15)
- Lee, Grace M. (34)
- Leidner, Andrew J. (8)
- Liang, Jennifer L. (15)
- Link-Gelles, Ruth (13)
- Long, Sarah S. (8)
- MacNeil, Jessica (14)
- MacNeil, Jessica R. (9)
- Marin, Mona (11)
- Markowitz, Lauri E. (37)
- Matanock, Almea (8)
- Mbaeyi, Sarah A. (10)
- McClung, Nancy (8)
- Melgar, Michael (8)
- Moore, Kelly L. (11)
- Morgan, Rebecca L. (11)
- Moulia, Danielle (9)
- Nelson, Noele (11)
- Nelson, Noele P. (8)
- Oliver, Sara E. (54)
- Ortega-Sanchez, Ismael R. (9)
- Pickering, Larry K. (8)
- Pilishvili, Tamara (25)
- Poehling, Katherine (10)
- Poehling, Katherine A. (16)
- Rao, Agam (14)
- Reingold, Arthur (18)
- Robinson, Candice L. (10)
- Romero, José R. (30)
- Rubin, Lorry (19)
- Sanchez, Pablo (8)
- Santoli, Jeanne M. (30)
- Sawyer, Mark (11)
- Schillie, Sarah F. (8)
- Shay, David K. (8)
- Shimabukuro, Tom T. (45)
- Sokolow, Leslie Z. (10)
- Staples, J. Erin (10)
- Stephens, David S. (13)
- Stoecker, Charles (8)
- Strikas, Raymond A. (8)
- Su, John R. (8)
- Szilagyi, Peter (8)
- Talbot, H. Keipp (32)
- Temte, Jonathan L. (10)
- Twentyman, Evelyn (9)
- Uyeki, Timothy M. (10)
- Wallace, Megan (26)
- Walter, Emmanuel B. (24)
- Wharton, Melinda (10)
- Williams, Walter W. (8)
- American Academy of Family Physicians (6)
- American Academy of Family Physicians. (24)
- American Academy of Pediatrics (4)
- American Academy of Pediatrics. (4)
- American Academy of Physician Assistants. (6)
- American College of Nurse-Midwives. (16)
- American College of Obstetricians and Gynecologists. (21)
- American College of Physicians. (9)
- Arkansas. Department of Health. (6)
- Baylor College of Medicine. (4)
- CDC COVID-19 Response Team. (9)
- CDC COVID-19 Vaccine Planning Unit. Vaccine Safety Team. (6)
- CDC COVID-19 Vaccine Task Force. Vaccine Safety Team. (14)
- Center for Disease Control (U.S.). Immunization Practices Advisory Committee. (29)
- Centers for Disease Control (U.S.). Immunization Practices Advisory Committee. (52)
- Centers for Disease Control and Prevention (U.S.) (115)
- Centers for Disease Control and Prevention (U.S.). Epidemic Intelligence Service. (9)
- Centers for Disease Control and Prevention (U.S.). Immunization Safety Office. (5)
- Communicable Disease Center (U.S.). Advisory Committee on Immunization Practices. (6)
- COVID-19 Vaccine Safety Technical (VaST) Work Group. (9)
- General Dynamics Information Technology. (4)
- GlaxoSmithKline. (5)
- GSK Vaccines. (11)
- Kaiser Permanente Colorado. Institute for Health Research. (6)
- Kaiser Permanente Vaccine Study Center. (8)
- Marshfield Clinic Research Institute. (7)
- Marshfield Clinic Research Institute. Vaccine Safety Datalink. Immunization Safety Office. (5)
- McMaster University. Faculty of Health Sciences. Department of Health Research Methods, Evidence, and Impact. (5)
- MedImmune, Inc. (6)
- Merck Research Laboratories. (12)
- Moderna (firm) (10)
- Nancy Lee & Associates. (5)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.) (5)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Healthcare Quality Promotion. Immunization Safety Office. (16)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. (11)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. Poxvirus and Rabies Branch. (8)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology. Viral Special Pathogens Branch. (6)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Vector-Borne Diseases. (5)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Vector-Borne Diseases. Arboviral Diseases Branch. (25)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Vector-Borne Diseases. Dengue Branch. (8)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Immunization Safety Office. (30)
- National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Viral Special Pathogens Branch. (6)
- National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.) (9)
- National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of STD Prevention. (11)
- National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Viral Hepatitis. (14)
- National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention (U.S.). Division of Viral Hepatitis. (10)
- National Center for Immunization and Respiratory Diseases (U.S.) (90)
- National Center for Immunization and Respiratory Diseases (U.S.). Coronavirus and Other Respiratory Viruses Division. (7)
- National Center for Immunization and Respiratory Diseases (U.S.). Division of Bacterial Diseases. (47)
- National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (66)
- National Center for Immunization and Respiratory Diseases (U.S.). Immunization Services Division. (83)
- National Center for Immunization and Respiratory Diseases (U.S.). Influenza Division. (53)
- National Center for Immunization and Respiratory Diseases (U.S.). Meningitis and Vaccine Preventable Diseases Branch. (6)
- National Center for Immunization and Respiratory Diseases (U.S.). Respiratory Diseases Branch. (9)
- National Center for Immunization and Respiratory Diseases (U.S.). US Flu VE Network. (10)
- National Center for Immunizations and Respiratory Diseases (U.S.). Respiratory Diseases Branch. (6)
- National Center for Infectious Diseases (U.S.) (5)
- National Center for Infectious Diseases (U.S.). Division of Viral and Rickettsial Diseases. (13)
- National Communicable Disease Center (U.S.). Advisory Committee on Immunization Practices. (10)
- National Immunization Program (Centers for Disease Control and Prevention) (22)
- National Immunization Program (Centers for Disease Control and Prevention). Epidemiology and Surveillance Division. (7)
- Pfizer Ltd. (9)
- Sanofi Pasteur. (10)
- Seqirus. (6)
- Stanford University School of Medicine. (11)
- Tulane University. School of Public Health and Tropical Medicine. (7)
- United States, Advisory Committee on Immunization Practices. (15)
- United States. Advisory Committee on Immunization Practices (9)
- United States. Advisory Committee on Immunization Practices. (554)
- United States. Advisory Committee on Immunization Practices. ACIP Flavivirus Vaccines Workgroup. (6)
- United States. Advisory Committee on Immunization Practices. Adult Immunization Work Group. (10)
- United States. Advisory Committee on Immunization Practices. Adult RSV Work Group. (15)
- United States. Advisory Committee on Immunization Practices. Anthrax Vaccine Work Group. (11)
- United States. Advisory Committee on Immunization Practices. Chikungunya Vaccines Work Group. (14)
- United States. Advisory Committee on Immunization Practices. Combined Immunization Schedule Work Group. (5)
- United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. (163)
- United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group. COVID-19 Vaccine Safety Technical (VaST) Subgroup. (5)
- United States. Advisory Committee on Immunization Practices. Dengue Vaccine Workgroup. (7)
- United States. Advisory Committee on Immunization Practices. Hepatitis Vaccines Work Group. (33)
- United States. Advisory Committee on Immunization Practices. Herpes Zoster Work Group. (14)
- United States. Advisory Committee on Immunization Practices. HPV Vaccines Work Group. (9)
- United States. Advisory Committee on Immunization Practices. Human Rabies Prevention Work Group. (10)
- United States. Advisory Committee on Immunization Practices. Influenza Work Group. (30)
- United States. Advisory Committee on Immunization Practices. Influenza Workgroup. (6)
- United States. Advisory Committee on Immunization Practices. JE Flavivirus Vaccine Workgroup. (5)
- United States. Advisory Committee on Immunization Practices. Maternal/Pediatric Respiratory Syncytial Virus (RSV) Work Group. (7)
- United States. Advisory Committee on Immunization Practices. Measles, Mumps, and Rubella (MMR) Vaccine Work Group. (6)
- United States. Advisory Committee on Immunization Practices. Meningococcal Vaccines Work Group. (19)
- United States. Advisory Committee on Immunization Practices. Meningococcal Work Group. (15)
- United States. Advisory Committee on Immunization Practices. Mpox Vaccine Work Group. (9)
- United States. Advisory Committee on Immunization Practices. Mumps Work Group. (5)
- United States. Advisory Committee on Immunization Practices. Pertussis Vaccines Work Group. (18)
- United States. Advisory Committee on Immunization Practices. Pertussis Vaccines Working Group. (5)
- United States. Advisory Committee on Immunization Practices. Pneumococcal Vaccines Work Group. (46)
- United States. Advisory Committee on Immunization Practices. Zoster Working Group. (5)
- United States. Public Health Service. (7)
- University of Michigan. School of Public Health. (7)
- University of Washington. (10)
- Valneva (5)
- Vanderbilt University School of Medicine. (11)
- Africa (1)
- Alabama (1)
- Arizona (1)
- Asia (4)
- Australia (2)
- California (1)
- Colorado (1)
- District of Columbia (1)
- Indiana (1)
- Los Angeles, CA (1)
- Louisiana (1)
- Maryland (1)
- Minnesota (1)
- New Jersey (1)
- New Mexico (1)
- New York City, NY (1)
- New Zealand (1)
- North Carolina (1)
- Paraguay (1)
- Puerto Rico (5)
- Rhode Island (1)
- Seattle, WA (1)
- Sierra Leone (1)
- South America (1)
- United States (320)
- Utah (1)
- Washington (1)
- Wisconsin (1)
[PDF - 1.53 MB]
Personal Author:Kondor, RebeccaOctober 26, 2023 | ACIP meeting InfluenzaDescription:07-influenza-kondor-508.pdfFile Type:[PDF - 1.53 MB]
File Type:[PDF - 1.53 MB]
[PDF - 1.21 MB]
Personal Author:Olson, Samantha M.October 26, 2023 | ACIP meeting InfluenzaDescription:06-influenza-olson-508.pdfFile Type:[PDF - 1.21 MB]
File Type:[PDF - 1.21 MB]
[PDF - 537.58 KB]
Personal Author:Kobayashi, MiwakoOctober 26, 2023 | ACIP meeting Pneumococcal vaccinesDescription:01-Pneumo-Kobayashi-508.pdfFile Type:[PDF - 537.58 KB]
File Type:[PDF - 537.58 KB]
[PDF - 1.02 MB]
Personal Author:Wallace, MeganOctober 26, 2023 | ACIP meeting COVID-19 VaccinesDescription:03-COVID-Wallace-508.pdfFile Type:[PDF - 1.02 MB]
File Type:[PDF - 1.02 MB]
[PDF - 939.91 KB]
Personal Author:Stokley, ShannonOctober 26, 2023 | ACIP meeting COVID-19 VaccinesDescription:02-COVID-Stokley-508.pdfFile Type:[PDF - 939.91 KB]
File Type:[PDF - 939.91 KB]
[PDF - 371.90 KB]
Personal Author:Daley, Matthew F.October 26, 2023 | ACIP meeting COVID-19 VaccinesDescription:01-COVID-Daley-508.pdfFile Type:[PDF - 371.90 KB]
File Type:[PDF - 371.90 KB]
[PDF - 417.51 KB]
Personal Author:Chen, WilburOctober 26, 2023 | ACIP meeting Dengue Virus vaccinesDescription:01-Dengue-chen-508.pdfFile Type:[PDF - 417.51 KB]
File Type:[PDF - 417.51 KB]
[PDF - 264.28 KB]
Personal Author:Hills, SusanOctober 26, 2023 | ACIP meeting Chikungunya vaccinesDescription:03-Chikungunya-Hills-508.pdfFile Type:[PDF - 264.28 KB]
File Type:[PDF - 264.28 KB]
[PDF - 1.37 MB]
Personal Author:Hills, SusanOctober 26, 2023 | ACIP meeting Chikungunya vaccinesDescription:02-Chikungunya-Hills-508.pdfFile Type:[PDF - 1.37 MB]
File Type:[PDF - 1.37 MB]
[PDF - 145.47 KB]
Personal Author:Bell, Beth P.October 26, 2023 | ACIP meeting Chikungunya vaccinesDescription:01-Chikungunya-Bell-508.pdfFile Type:[PDF - 145.47 KB]
File Type:[PDF - 145.47 KB]
[PDF - 25.61 MB]
Personal Author:Murthy, NeilOctober 26, 2023 | ACIP meeting Combined Immunization ScheduleDescription:03-IZ-Schedules-Murthy-508.pdfFile Type:[PDF - 25.61 MB]
File Type:[PDF - 25.61 MB]
[PDF - 28.87 MB]
Personal Author:Cineas, Sybil ;Wodi, A. Patricia...October 26, 2023 | ACIP meeting Combined Immunization ScheduleDescription:Title from conference agenda.First slide has title: Recommendations from the Combined Immunization Schedule WG for the 2024 Immunization Schedules for...File Type:[PDF - 28.87 MB]
File Type:[PDF - 28.87 MB]
[PDF - 1.04 MB]
Personal Author:Cineas, Sybil ;Wodi, A. Patricia...October 26, 2023 | ACIP meeting Combined Immunization ScheduleDescription:01-IZ-Schedules-Cineas-508.pdfFile Type:[PDF - 1.04 MB]
File Type:[PDF - 1.04 MB]
[PDF - 669.94 KB]
Personal Author:Shimabukuro, Tom T.October 25, 2023 | Vaccine Safety UpdateDescription:01-VaxSafety-Shimabukuro-508.pdfFile Type:[PDF - 669.94 KB]
File Type:[PDF - 669.94 KB]
[PDF - 694.87 KB]
Personal Author:Schmader, KennethOctober 25, 2023 | ACIP meeting InfluenzaDescription:(ClinicalTrials.gov ID: NCT05007041)05-Influenza-Schmader-508.pdfFile Type:[PDF - 694.87 KB]
File Type:[PDF - 694.87 KB]
[PDF - 840.64 KB]
Personal Author:Walter, EmmanuelOctober 25, 2023 | ACIP meeting InfluenzaDescription:(ClinicalTrials.gov ID: NCT05028361)04-Influenza-Walter-508.pdfFile Type:[PDF - 840.64 KB]
File Type:[PDF - 840.64 KB]
[PDF - 232.79 KB]
Personal Author:Sylvester, Gregg C.October 25, 2023 | ACIP meeting InfluenzaDescription:03-influenza-sylvester.pdfFile Type:[PDF - 232.79 KB]
File Type:[PDF - 232.79 KB]
[PDF - 349.85 KB]
Personal Author:Klein, NicolaOctober 25, 2023 | ACIP meeting InfluenzaDescription:02-influenza-klein-508.pdfFile Type:[PDF - 349.85 KB]
File Type:[PDF - 349.85 KB]
[PDF - 251.79 KB]
Personal Author:Loehr, JamieOctober 25, 2023 | ACIP meeting InfluenzaDescription:01-influenza-Loehr-508.pdfFile Type:[PDF - 251.79 KB]
File Type:[PDF - 251.79 KB]
[PDF - 641.35 KB]
Personal Author:Britton, AmadeaOctober 25, 2023 | ACIP meeting Respiratory Syncytial Virus (RSV) Older Adults VaccineDescription:04-Britton-Adult-RSV-508.pdfFile Type:[PDF - 641.35 KB]
File Type:[PDF - 641.35 KB]
Exit Notification/Disclaimer Policy
Links with this icon indicate that you are leaving the CDC website.
- The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
- Linking to a non-federal Website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
- You will be subject to the destination website's privacy policy when you follow the link.
- CDC is not responsible for Section 508 compliance (accessibility) on other federal or private websites.